Back
Arcutis Biotherapeutics Vs. Exicure Industry Stock Comparison
Sell
26
ARQT
Arcutis Biotherapeutics
Last Price:
11.71
Seasonality Move:
101.78%
Buy
62
XCUR
Exicure
Last Price:
30.86
Seasonality Move:
-4.03%
Sell
26
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $11.71. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Exicure (XCUR)
is a Buy
Is Exicure a Buy, Sell or Hold?
- The current Exicure [XCUR] share price is $31.99. The Score for XCUR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- XCUR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $11.71
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight buying pressure.
XCUR Stock Price Chart
ARQT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 69.25 | Buy |
| Chaikin Money Flow: | 542611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.78 - 10.74) | Buy |
| Bollinger Bands (100): | (8.97 - 10.57) | Buy |
XCUR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.9 | Buy |
| Relative Strength Index (14 RSI): | 95.88 | Buy |
| Chaikin Money Flow: | 80777 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (-1.39 - 16.11) | Buy |
| Bollinger Bands (100): | (-1.28 - 8.54) | Buy |
ARQT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.51 | Buy |
| 20-day SMA: | 10.05 | Buy |
| 50-day SMA: | 9.64 | Buy |
| 200-day SMA: | 9.57 | Buy |
| 8-day EMA: | 10.76 | Buy |
| 20-day EMA: | 10.2 | Buy |
| 50-day EMA: | 9.84 | Buy |
| 200-day EMA: | 9.23 | Buy |
XCUR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.08 | Buy |
| 20-day SMA: | 8.58 | Buy |
| 50-day SMA: | 5.2 | Buy |
| 200-day SMA: | 3.1 | Buy |
| 8-day EMA: | 19.83 | Buy |
| 20-day EMA: | 11.91 | Buy |
| 50-day EMA: | 6.88 | Buy |
| 200-day EMA: | 3.97 | Buy |
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.
Exicure Earnings Growth & XCUR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Arcutis Biotherapeutics Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Exicure Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||